Moreover, blocking CTLA-4 enhances the antigen-presenting process, or the subsequent immune system attack is enhanced by blocking PD-1/PD-L1, finally establishing a stronger adaptive immune system to kill cancer cells. Here, CD274 is linked to cancer.